It has been four years since the Supreme Court overturned Roe v. Wade with its decision in Dobbs v. Jackson Women's Health Organization, ending the constitutional right to abortion that had stood for nearly five decades.
The June 24, 2022 ruling allowed states to immediately implement "trigger laws" that had been waiting for the court's permission to restrict abortion. But several developments since then have surprised observers on all sides of the debate, including the role of telemedicine and mail-order medications in maintaining access even in states with near-total bans.
This year, voters will again consider ballot measures to protect or restrict abortion access across multiple states. Meanwhile, dramatic stories of medical care denied continue to unfold, and legal challenges over medication abortion are heading toward the Supreme Court once more.
What the Left Is Saying
Abortion rights advocates say the post-Dobbs landscape has demonstrated that medication abortion is resilient despite legal battles. "Abortion pills are everywhere, they're safe, they're effective, and they're pretty much unstoppable," said Elisa Wells of Plan C, a website about medication abortion. "The genie is out of the bottle."
Progressive groups point to shield laws as a major success story, noting that clinicians in states supportive of abortion access have been able to serve residents of banned states through telemedicine prescriptions and mail-order medications.
Researchers at University of California San Francisco recently published a study examining whether medication abortion could be made available over-the-counter without any prescription required. A Planned Parenthood affiliate has begun offering abortion medication proactively to patients who are not currently pregnant, so they can have it on hand if needed.
Abortion rights supporters argue that the growing willingness of women to speak publicly about their experiences represents progress in reducing stigma. Hashtags like #ShoutYourAbortion and high-profile cases like Kate Cox, who appealed to the Texas Supreme Court for access to abortion while pregnant, have brought national attention to the consequences of state bans.
What the Right Is Saying
Anti-abortion activists note that despite the rise in medication abortions, many brick-and-mortar reproductive health clinics have closed since Dobbs. They point to congressional Republicans withholding millions of dollars from Planned Parenthood and similar organizations as a contributing factor, arguing this has reduced access to abortion providers.
Conservative legal advocates are pursuing aggressive strategies through existing laws. Justice Clarence Thomas wrote in a dissent related to the abortion pill case that the Comstock Act, an ineteenth-century law restricting mailing of items intended for abortion, remains in force and that drug companies manufacturing FDA-approved medications were engaged in a "criminal enterprise."
Several states have taken action against medication abortion. Louisiana scheduled mifepristone and misoprostol as controlled substances and is suing the Food and Drug Administration to reverse rules allowing telemedicine access to the drugs. Texas passed legislation allowing private citizens to sue out-of-state prescribers of abortion pills for $100,000.
Some state legislatures are considering bills that would classify obtaining an abortion as homicide. Anti-abortion groups argue these measures reflect the consistent position that life begins at conception and deserve legal protection.
What the Numbers Show
The number of abortions nationally has increased each year since Dobbs, contrary to what many predicted when more than a dozen states implemented bans. Policy changes in supportive states have lowered barriers such as waiting periods and parental permission requirements.
Shield laws have enabled clinicians to prescribe medication abortion via telemedicine without patients traveling, leading to an increase in abortions occurring even in banned states through mail-order pills.
The Guttmacher Institute, which tracks abortion data, reported that medication abortion now accounts for more than half of all abortions performed in the United States. This represents a significant shift from pre-Dobbs patterns.
Clinicians report having contingency plans to continue sending at least one of the two medications used in medication abortion through the mail even if access to mifepristone is restricted by future court decisions.
The Bottom Line
The post-Dobbs landscape remains in flux with multiple legal cases pending before federal courts. A Louisiana case challenging FDA rules on telemedicine access to mifepristone is likely headed for the Supreme Court and could determine whether medication abortion remains available via prescription nationally.
President Trump's administration has been notably quiet on abortion policy during this midterm year, reflecting the political complexity of an issue where his coalition includes independent voters who support abortion rights alongside anti-abortion activists demanding further restrictions.
Privacy concerns have emerged as a new dimension of the debate. Police in Nebraska used Facebook messages to prosecute a woman for providing abortion pills to her teenage daughter, raising questions about digital privacy and law enforcement access to personal data. Period-tracking apps have also drawn scrutiny from privacy experts.
What happens next will likely depend on pending litigation over medication abortion access, state ballot measures in November, and whether the Comstock Act is enforced by the Justice Department. The issue shows no signs of fading from American political life.